National Security & Policy - Tariffs under Section 232 are likely due to a perceived national security crisis [1] - The administration aims to achieve "pharma independence" through a multi-step plan [3] - The plan involves strategic API (原料药) reserve establishment [1] - Government contracts from DH (国土安全部), Veterans Affairs, DoD (国防部), and HHS (卫生与公众服务部) will provide stable demand [2] Supply Chain & Vulnerability - The current situation is characterized as an "extreme vulnerability" [2] - The goal is to shift towards an "America first, America farmer first" approach [2]